TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
PROK

ProKidney Corp.

Healthcare · Biotechnology

1.60$ +0.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PROK
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +111,088.0% +105.8% +53.0% +26.9% +41.0% +21.0%
– +146,486.3% -4.2% +10,553.6% -58.6% -4.8% -13.7%
– +46.6% -4.2% +10,553.6% – – –
– – – -398.5% – -76.3% -67.6%
– +417,984.3% -4.8% -64.4% +1,752.5% -13.7% -48.5%
– +183,727.5% -4.9% -66.5% +18,886.4% – +409.3%
– – – – -101.8% -100.0% –
– +0.0% +172.7% +6.7% +62.5% +3.8% -51.9%
– +99,845.0% +257.5% +667.5% -101.7% – -82.3%
– -70,033.0% – +2,839.3% -191.5% – -75.5%
– – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?